查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1836774

氧氣療法設備市場（按產品類型、技術、最終用戶和應用）—全球預測 2025-2032

Oxygen Therapy Devices Market by Product Type, Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，氧氣療法設備市場規模將成長至 46.8 億美元，複合年成長率為 6.99%。

主要市場統計數據
基準年2024年 27.3億美元
預計2025年 29.1億美元
預測年份：2032年 46.8億美元
複合年成長率（%） 6.99%

氧氣療法設備的精彩介紹：揭示臨床促進因素，包括以患者為中心的採用趨勢、技術創新和護理服務方式的轉變

氧氣療法設備如今廣泛應用於各種臨床環境，從急診醫院到居家管理項目，並在現代呼吸護理中發揮核心作用。設備便攜性、能源效率和降噪方面的進步正在重塑患者的期望，並推動著向門診病人和居家醫療模式的轉變。隨著臨床指引日益強調早期療育、持續照護和以病人為中心的治療方案，氧氣療法的設計和實施也在不斷發展，以滿足臨床有效性和生活方式的考量。

同時，醫療保健提供者和設備製造商正在應對不斷變化的報銷模式，並不斷加強與數位醫療的整合。遠端監控、遠端醫療支援的依從性追蹤以及數據驅動的治療最佳化正在擴展氧氣系統的價值提案，使其超越簡單的氣體輸送。最終的結果是形成一個動態的環境，臨床需求、法律規範和技術能力相互交織，為採用和差異化開闢了新的途徑。本引言將組裝影響急性和非急性照護中採購決策、臨床通訊協定和供應鏈策略的關鍵促進因素，為後續分析提供框架。

臨床實務技術和供應鏈策略的轉型將重塑氧氣療法設備的設計、製造和部署方式

氧氣療法設備領域正在經歷一場變革，涵蓋臨床實踐、技術和供應鏈架構。臨床上，護理的去中心化趨勢明顯，曾經僅限於住院治療的治療，如今已在門診手術中心和家中進行。這種轉變是由攜帶式氧氣濃縮機的進步、低耗電量以及整合監測功能所推動的，這些技術都有助於提高患者的活動能力和依從性。因此，製造商優先考慮使用者體驗、電池效率和整合數位功能，以滿足患者的實際需求。

同時，技術發展軌跡也為氧氣的生產和輸送提供了更多選擇。變壓式吸附和薄膜技術已經成熟，可以支援現場製氧和緊湊型設計，從而減少某些護理情況下對氣瓶發行的物流依賴。低溫蒸餾仍然是大規模液態氧輸送的首選方法，因為規模經濟可以證明集中生產的合理性。因此，不同的技術基於規模、移動性和輸送成本的考量，正在開拓不同的市場。

供應鏈創新也是一個決定性的轉變。為了因應貿易政策的不確定性以及維持臨床連續性的需要，區域製造和近岸外包策略正日益受到青睞。製造商正在實現壓縮機、篩床和電子控制模組等關鍵零件供應商的多元化，以降低單一來源風險。最後，監管和報銷制度的變化正在推動臨床證據生成與產品開發之間更加緊密的銜接，鼓勵製造商投資於能夠證明療效並支持在醫療機構中推廣的臨床和療效研究。

評估2025年美國關稅對製造業採購定價權和競爭力的累積影響

2025年關稅對氧氣療法設備生態系統產生了累積影響，改變了採購、生產和分銷的經濟效益。進口零件和成品設備關稅上調促使製造商重新評估長期以來的籌資策略，並加速了對本地生產和供應商多元化的興趣。隨著關稅上調導致某些進口產品的到岸成本上升，現有企業和新參與企業都在權衡本地製造產能的資本投資與供應鏈重組帶來的短期成本壓力之間的利弊。

這種環境也影響著策略定價和合約行為。付款人和機構投資者要求更清楚地了解整體擁有成本，包括服務、維護和物流，這促使供應商完善其基於價值的提案和捆綁式報價。同時，一些製造商正在加速產品重新設計，以減少對受關稅影響組件的依賴，優先考慮模組化和使用更容易採購的子組件。因此，市場競爭力如今取決於能否展現營運韌性、合約彈性和供應安全性。

此外，隨著企業試圖遷移或擴大生產規模，監管時間表和跨境認證流程已成為重大摩擦點。相關人員擴大將貿易政策情境規劃與監管機構的溝通結合起來，以避免設備供應中斷。總而言之，關稅環境不僅影響短期成本結構，也影響生產地點、供應商關係和商業性提案的長期策略調整。

關鍵細分洞察揭示了產品類型技術、最終用戶和臨床應用如何塑造差異化的採用路徑和服務要求

細分顯示，不同產品採用路徑存在細微差異，這些路徑因產品設計、實行技術、醫療環境和臨床應用而異。從產品類型來看，液氧系統仍然與集中供應模式相關，在這種模式下，高容量需求和倉儲物流是其合理使用的理由；氧氣濃縮機主要應用於需要持續門診或居家使用的場景；而氧氣瓶則繼續用於應對偶發性和緊急需求。在氧氣濃縮機類別中，攜帶式和固定式設備的區別決定了購買標準：攜帶式設備優先考慮移動性和生活品質，而固定式設備則適用於在固定護理場所進行持續可靠的治療。

技術選擇與產品選擇相互交織，並決定了營運的權衡。低溫蒸餾支持大型液體供應鏈，通常與集中式基礎設施相關；而變壓式吸附則憑藉其效率和擴充性的平衡，在現場發電和緊湊型濃縮器設計中佔據主導地位。這些技術差異會影響維護方法、生命週期考量和總成本動態，進而指南不同買家的採購偏好。

最終用戶有明確的要求，這些要求會影響設備規格和服務模式。門診手術中心要求快速的設備設置、標準化的維護通訊協定和緊湊的解決方案。家庭醫療保健提供者優先考慮易於設定、低噪音和遠端監控功能，以支援患者依從性。醫院和診所通常要求設備具有強大的臨床認證、整合到治療通訊協定中並具有可預測的服務等級協定。氣喘和其他慢性肺部疾病通常強調長期依從性和舒適性，慢性阻塞性肺病需要可靠的氧濃度滴定和持久運行，阻塞型睡眠呼吸中止症明確考慮夜間分娩，肺炎和呼吸窘迫症候群需要快速反應並與急性護理工作流程相容。整合產品、技術、最終用戶和應用視角使相關人員能夠根據差異化的臨床和營運需求調整研發重點和打入市場策略。

影響美洲、歐洲、中東和非洲以及亞太地區氧氣療法設備的區域力量及其對製造和市場進入的實際影響

區域動態顯著影響氧氣療法設備的製造、監管和商業化方式。在美洲，買家通常看重快速取得、整合服務網路和與報銷掛鉤的採購方式，青睞能夠提供強大售後服務和臨床證據的供應商。尤其是美國市場對法規合規性和數據整合有著很高的標準，鼓勵製造商將產品開發與當地認證和臨床試驗預期相結合。相較之下，拉丁美洲市場則優先考慮經濟高效的解決方案和靈活的維護機制，這可能為建立靈活的服務模式和區域夥伴關係關係創造機會。

在歐洲、中東和非洲，多樣化的法規和不斷變化的醫療基礎設施需要靈活的通路策略。同時，中東和非洲國家將快速現代化的醫療體系與資源受限的環境結合。在許多此類環境中，能夠提供在電力和物流受限的環境中運行的可擴展解決方案是一項競爭優勢。同時，亞太地區呈現多樣化的格局。在一些國家，成熟的醫療體系需要功能豐富的設備和數位化整合，而新興市場則優先考慮價格承受能力和本地服務能力。亞太地區的製造地也對全球供應發揮戰略作用，影響企業如何跨時區和貿易走廊分配生產和管理分銷。

整體而言，區域差異將影響產品組合、定價策略和合作模式的決策。根據當地臨床方案和基礎設施的實際情況客製化產品的製造商將能夠更有效地進入市場並獲得持續的採用。

重新定義供應鏈創新投資夥伴關係和服務交付模式的公司層級策略發展和競爭行為

公司層面的競爭態勢以產品創新、策略夥伴關係和服務擴展相結合為特徵。領先的公司正在投資濃縮器效率、電池壽命和使用者介面的漸進式改進，同時探索遠端監控和遠端患者管理等領域的協同機會。這些努力通常與醫療保健提供者和技術供應商建立策略聯盟相輔相成，從而能夠快速整合到臨床工作流程中並簡化證據產生。

新參與企業和專業製造商瞄準具有明確價值提案的利基市場，例如超輕型可攜式聚光器和專為分散式設施量身定做的模組化現場發電系統。現有企業則透過增強服務能力、擴展維護網路以及選擇性收購來填補技術和地理空白，以應對這一市場。供應鏈彈性已成為一個競爭關鍵，促使企業投資於多源採購、區域倉儲和預測性維護計劃，以減少停機時間並提高客戶維繫。

對於尋求加快產品核准並使產品核可符合當地臨床指南的公司來說，與監管機構的合作也成為一項關鍵挑戰。擁有強大的臨床資料集和清晰的上市後監測計劃的公司，更有機會獲得機構管道的支援。最後，商業性策略也越來越強調加值附加價值服務，例如療效追蹤、依從性分析和整合耗材管理。

為行業領導者提供可行的建議，以最佳化產品系列、增強供應彈性、利用數位健康並加速商業性執行

行業領導者可以採取一系列切實可行的優先事項，以在快速發展的氧氣療法市場中抓住機會並管理風險。首先，優先考慮模組化產品架構，以減少對受關稅影響元件的依賴，並實現快速在地化生產。這種方法既有助於控制成本，又能靈活回應當地監管要求。其次，加快對攜帶式濃縮器功能和電池創新的投資，以順應居家醫療和患者移動化趨勢。

第三，我們將把數位醫療功能嵌入到我們的設備生態系統中，以實現遠端監控、依從性支援和數據驅動的臨床決策。整合遠端醫療功能將增強產品差異化，並支持付款人圍繞療效和價值進行對話。第四，我們將透過多元化供應商、建立區域製造夥伴關係以及投資預測性維護框架來增強供應鏈的韌性，以最大限度地減少服務中斷。第五，我們將積極與監管機構和付款人合作，使臨床證據要求與報銷途徑一致，從而加快機構環境的採用。

最後，採用靈活的商業模式，將服務合約和基於績效的要素與設備銷售結合。透過轉向以價值為導向的合約和全面的服務，製造商可以建立更牢固的客戶關係，同時平滑收益波動。各組織可以協作實施這些建議，以維持整個醫療保健領域的成長選擇，同時應對政策變革、技術變革和不斷變化的臨床期望。

調查方法和資料來源採用嚴格的混合方法，結合初步研究和技術檢驗，並跨多個資料來源進行三角測量以確保準確性。

本分析所依據的研究採用了嚴格的混合方法，以確保可靠性和實用效度。初步研究包括對臨床醫生、生物醫學工程師、採購主管和設備製造商的結構化訪談，以獲得關於設備性能、服務期望和採用障礙的第一手見解。二次研究整合了廣泛的公開資訊來源，包括監管備案文件、臨床指南、專利文獻和技術白皮書，以檢驗技術和監管背景。對一手和二次研究的數據進行迭代三角檢驗，以協調不同的觀點並提高定性研究觀察的可靠性。

分析步驟包括對訪談記錄進行主題編碼、識別反覆出現的痛點和機會領域、交叉比較產品規格以確定功能差異，以及透過情境分析對貿易政策變化和供應鏈中斷的戰略應對措施進行壓力測試。專家審查了研究結果初稿，以確保技術準確性並確保結論與當前臨床實踐相符。在適用的情況下，明確記錄了調查方法的局限性和假設，以幫助解讀並指南使用者根據自身工作情況調整研究見解。

總結性綜合報告匯集了臨床、技術、監管和商業性主題，為相關人員闡明了機會和策略要務

最終的綜合報告匯集了臨床、技術、監管和商業主題，闡明了對相關人員的策略重要性。臨床驅動的分散化，加上攜帶式濃縮器技術的進步和支持性的數位生態系統，為家庭醫療保健和門診環境的成長開闢了清晰的道路，同時在某些大批量生產情況下仍保留了集中式液態氧的作用。監管和政策變化（包括貿易相關措施）再形成製造和採購的優先事項，提升了區域產能和供應商多元化的重要性。

商業性成功取決於能否將產品創新與可證明的臨床價值和可靠的服務交付相結合。能夠將高效的設備平台與強大的售後服務網路和數據驅動服務相結合的公司將更有能力贏得持久的客戶關係。總而言之，氧氣療法治療設備產業正進入一個臨床需求、技術成熟度和政策動態融合的階段，推動策略差異化發展。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 將支援物聯網的遠端監控功能整合到氧氣療法設備中，以支援遠端醫療服務。
  • 開發一種結合連續流量和脈衝劑量的混合氧氣濃縮機，為患者提供靈活性
  • 家庭氧氣療法報銷政策的擴大正在推動慢性呼吸系統疾病患者擴大採用家庭氧氣治療
  • 小型輕量攜帶式氧氣設備的進步延長了戶外活動期間的電池壽命
  • 人工智慧驅動的氧氣輸送系統根據即時患者健康指標最佳化流速

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章氧氣療法設備市場（依產品類型）

  • 液態氧系統
  • 氧氣濃縮機
    • 可攜帶式氧氣設備
    • 固定式氧氣濃縮機
  • 氧氣罐

第9章氧氣療法設備市場（按技術）

  • 低溫蒸餾
  • 膜分離
  • 變壓式吸附

第 10 章氧氣療法設備市場（依最終用戶）

  • 門診手術中心
  • 家庭醫療保健
  • 醫院和診所

第 11 章氧氣療法設備市場（按應用）

  • 氣喘和其他肺部疾病
  • 慢性阻塞性肺病（COPD）
  • 阻塞型睡眠呼吸中止症症（OSA）
  • 肺炎和呼吸窘迫症候群

第12章氧氣療法設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章氧氣療法設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章氧氣療法設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Koninklijke Philips NV
    • ResMed Inc.
    • Chart Industries, Inc.
    • Inogen, Inc.
    • Drive DeVilbiss Healthcare, Inc.
    • Invacare Corporation
    • GE HealthCare Technologies Inc.
    • Parker-Hannifin Corporation
    • Nidek Medical Products, Inc.
    • O2 Concepts, Inc.
Product Code: MRR-036C5CF3B4F1

The Oxygen Therapy Devices Market is projected to grow by USD 4.68 billion at a CAGR of 6.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.73 billion
Estimated Year [2025] USD 2.91 billion
Forecast Year [2032] USD 4.68 billion
CAGR (%) 6.99%

A compelling introduction to oxygen therapy devices delineating clinical drivers patient-centric adoption trends technological innovations and care delivery shifts

Oxygen therapy devices now occupy a central role in contemporary respiratory care, serving a spectrum of clinical settings from acute hospitals to home-based management programs. Advances in device portability, power efficiency, and noise reduction have reshaped patient expectations and enabled a greater shift toward outpatient and home healthcare models. As clinical guidelines increasingly emphasize early intervention, continuity of care, and patient-centric regimens, the design and delivery of oxygen therapy are evolving to meet both clinical efficacy and lifestyle considerations.

At the same time, care providers and device manufacturers are responding to shifting reimbursement paradigms and the growing integration of digital health. Remote monitoring, telehealth-enabled adherence tracking, and data-driven therapy optimization are expanding the value proposition of oxygen systems beyond simple gas delivery. The net effect is a dynamic environment in which clinical demand, regulatory oversight, and technological capability intersect to create new pathways for adoption and differentiation. This introduction frames the subsequent analysis by highlighting the primary drivers that are shaping purchasing decisions, clinical protocols, and supply chain strategies across acute and non-acute care settings.

Transformative shifts in clinical practice technology and supply chain strategies that are reshaping how oxygen therapy devices are designed produced and deployed

The landscape for oxygen therapy devices is undergoing transformative shifts that span clinical practice, technology, and supply chain architecture. Clinically, there is an evident move toward decentralization of care: treatments once confined to inpatient settings are now delivered in ambulatory surgical centers and the home. This transition is propelled by advances in portable oxygen concentrators, lower power consumption, and the integration of monitoring capabilities, all of which support greater patient mobility and adherence. Consequently, manufacturers are prioritizing user experience, battery efficiency, and integrated digital features to align with real-world patient needs.

Concurrently, technological trajectories are multiplying options for oxygen production and delivery. Pressure swing adsorption and membrane technologies have matured to support on-site generation and compact designs, reducing logistical dependence on cylinder distribution in certain care contexts. Cryogenic distillation remains relevant for large-scale liquid oxygen supply where economies of scale justify centralized production. As a result, different technologies are carving distinct niches based on scale, mobility, and cost-to-serve considerations.

Supply chain innovation is another defining shift. Regional manufacturing and nearshoring strategies are gaining traction in response to trade policy volatility and the imperative to maintain clinical continuity. Manufacturers are diversifying supplier bases for critical components such as compressors, sieve beds, and electronic control modules to reduce single-source risks. Finally, regulatory and reimbursement changes are prompting closer alignment between clinical evidence generation and product development, encouraging manufacturers to invest in clinical studies and outcomes research that substantiate effectiveness and support uptake across varied care settings.

Evaluating the cumulative consequences of United States tariff measures in 2025 on manufacturing sourcing pricing dynamics and competitive repositioning across the sector

The imposition of tariff measures in 2025 has exerted a cumulative influence on the oxygen therapy devices ecosystem, altering the economics of sourcing, production, and distribution. Increased duties on imported components and finished devices have incentivized manufacturers to revisit long-established procurement strategies, accelerating interest in local production and supplier diversification. As tariffs raise landed costs for certain imports, incumbent players and new entrants have been evaluating the trade-offs between capital investment in regional manufacturing capacity and the short-term cost pressures associated with reconfigured supply chains.

This environment has also influenced strategic pricing and contracting behavior. Payers and institutional buyers are seeking greater clarity around total cost of ownership, including service, maintenance, and logistics, which has led suppliers to refine value-based propositions and bundled offerings. In parallel, some manufacturers have accelerated product redesigns to reduce reliance on tariff-exposed components, prioritizing modularity and the use of more readily sourced subcomponents. The net result is a market in which operational resilience, contractual flexibility, and the ability to demonstrate consistent supply have become central competitive differentiators.

Moreover, regulatory timelines and cross-border certification processes have surfaced as critical friction points when companies attempt to relocate or scale manufacturing. Stakeholders are increasingly combining trade-policy scenario planning with regulatory engagement to avoid disruptions to device availability. Taken together, the tariff environment has not only influenced near-term cost structures but also catalyzed longer-term strategic adjustments in production footprints, supplier relationships, and commercial propositions.

Key segmentation insights revealing how product types technologies end users and clinical applications shape differentiated adoption pathways and service requirements

Segmentation reveals nuanced pathways to adoption that vary according to product design, enabling technology, care setting, and clinical application. When viewed through the lens of product type, liquid oxygen systems remain relevant for centralized supply models where high-volume demand and storage logistics justify their use, oxygen concentrators dominate scenarios requiring sustained ambulatory or home use, and cylinders continue to serve episodic and emergency needs. Within the concentrator category, distinctions between portable units and stationary systems shape purchase criteria, with portable devices prioritized for mobility and quality-of-life considerations and stationary units chosen for continuous, reliable therapy in fixed care locations.

Technology choices intersect with product selection to inform operational trade-offs. Cryogenic distillation underpins large-scale liquid supply chains and is typically associated with centralized infrastructure. Membrane separation technologies provide lighter-weight options that can be favorable in portable and decentralized contexts, while pressure swing adsorption has become a mainstream choice for both on-site generation and compact concentrator designs due to its balance of efficiency and scalability. These technology differentials influence maintenance practices, lifecycle considerations, and total cost dynamics, and therefore guide procurement preferences across different buyers.

End users exhibit distinct requirements that impact device specification and service models. Ambulatory surgical centers demand rapid device readiness, standardized maintenance protocols, and compact footprint solutions. Home healthcare providers prioritize easy setup, low noise emissions, and remote monitoring capabilities to support patient adherence. Hospitals and clinics typically require devices with robust clinical certifications, integration into therapeutic protocols, and predictable service-level agreements. Finally, clinical application drives clinical efficacy expectations and device customization: asthma and other chronic lung conditions often emphasize long-term adherence and comfort, chronic obstructive pulmonary disease requires reliable oxygen titration and durable operation, obstructive sleep apnea presents distinct nocturnal delivery considerations, and pneumonia and respiratory distress syndromes necessitate rapid responsiveness and compatibility with acute care workflows. By integrating product, technology, end-user, and application lenses, stakeholders can align R&D priorities and go-to-market strategies with differentiated clinical and operational needs.

Regional forces shaping oxygen therapy devices across the Americas Europe Middle East and Africa and Asia-Pacific with practical implications for manufacturing and market access

Regional dynamics exert a material influence on how oxygen therapy devices are manufactured, regulated, and commercialized. In the Americas, buyers often emphasize rapid access, integrated service networks, and reimbursement-aligned purchasing, which favors suppliers that can demonstrate robust aftersales support and clinical evidence. The United States market in particular drives high standards for regulatory compliance and data integration, prompting manufacturers to align product development with local certification and clinical trial expectations. In contrast, Latin American markets may prioritize cost-effective solutions and flexible maintenance arrangements, creating opportunities for adaptable service models and regional partnerships.

Across Europe, the Middle East, and Africa, regulatory diversity and variable healthcare infrastructure require flexible channel strategies. Western European markets typically mandate stringent clinical validation and benefit from established hospital procurement frameworks, while countries across the Middle East and Africa present a mix of rapid modernizing healthcare systems and resource-constrained environments. In many of these settings, the ability to offer scalable solutions that can operate in constrained power and logistics conditions is a competitive advantage. Meanwhile, Asia-Pacific displays a broad spectrum of circumstances: mature healthcare systems in some countries demand feature-rich devices and digital integration, whereas emerging markets prioritize affordability and local service capability. Manufacturing footprints in Asia-Pacific also play a strategic role for global supply, shaping how companies allocate production and manage distribution across time zones and trade corridors.

Taken together, regional variation informs decisions on product configuration, pricing strategies, and partnership models. Manufacturers that align their offerings to regional clinical protocols and infrastructure realities can achieve more effective market entry and sustained adoption.

Strategic company level developments and competitive behaviors that are redefining supply chains innovation investments partnerships and service delivery models

Competitive dynamics at the company level are characterized by a mix of product innovation, strategic partnerships, and service expansion. Leading firms are investing in incremental improvements to concentrator efficiency, battery life, and user interfaces while simultaneously exploring adjacent opportunities in telemonitoring and remote patient management. These efforts are often complemented by strategic alliances with healthcare providers and technology vendors that enable faster integration into clinical workflows and streamline evidence generation.

New entrants and specialized manufacturers are targeting niche segments with distinct value propositions, such as ultra-lightweight portable concentrators or modular on-site generation systems tailored for decentralized facilities. Established companies are responding by reinforcing their service capabilities, expanding maintenance networks, and pursuing selective acquisitions to fill technological or geographic gaps. Supply chain resilience has become a competitive battleground, prompting investments in multi-source procurement, regional warehousing, and predictive maintenance programs to reduce downtime and improve customer retention.

Regulatory engagement is also prominent as companies seek to expedite product approvals and align labeling with regional clinical guidelines. Firms that combine robust clinical data packages with clear post-market surveillance plans are better positioned to gain traction in institutional channels. Finally, the commercial playbook increasingly emphasizes value-added services-such as outcome tracking, adherence analytics, and integrated consumables management-that create recurring revenue streams and strengthen customer relationships across acute and non-acute care settings.

Actionable recommendations for industry leaders to optimize product portfolios strengthen supply resilience leverage digital health and accelerate commercial execution

Industry leaders can pursue a set of actionable priorities to capture opportunity and manage risk in a rapidly evolving oxygen therapy market. First, prioritize modular product architectures that reduce dependence on tariff-exposed components and allow faster localization of production. This approach supports both cost containment and agility in responding to regional regulatory requirements. Second, accelerate investment in portable concentrator capabilities and battery innovations, which align directly with the trend toward home-based care and patient mobility.

Third, embed digital health features into device ecosystems to enable remote monitoring, adherence support, and data-driven clinical decision-making. Integrating telehealth capabilities enhances product differentiation and supports payer conversations about outcomes and value. Fourth, fortify supply chain resilience by diversifying suppliers, establishing regional manufacturing partnerships, and investing in predictive maintenance frameworks to minimize service interruptions. Fifth, engage proactively with regulatory authorities and payers to align clinical evidence requirements with reimbursement pathways, thereby reducing time-to-adoption in institutional settings.

Finally, adopt flexible commercial models that combine device sales with service contracts and outcome-based elements. By shifting toward value-oriented agreements and comprehensive service offerings, manufacturers can create stickier customer relationships while smoothing revenue volatility. Executed in concert, these recommendations will help organizations navigate policy shifts, technological change, and evolving clinical expectations while preserving growth options across care settings.

Research methodology outlining a rigorous mixed methods approach that combines primary interviews technical validation and multi source data triangulation to ensure accuracy

The research underpinning this analysis employed a rigorous mixed-methods approach designed to ensure reliability and practical relevance. Primary research included structured interviews with clinicians, biomedical engineers, procurement leaders, and device manufacturers to surface first-hand insights on device performance, service expectations, and adoption barriers. Secondary research incorporated a wide range of publicly available sources such as regulatory filings, clinical guidelines, patent literature, and technical white papers to validate technological and regulatory context. Data from both primary and secondary streams were subjected to iterative triangulation to reconcile divergent perspectives and enhance confidence in qualitative findings.

Analytical steps included thematic coding of interview transcripts to identify recurring pain points and opportunity areas, cross-comparison of product specifications to map functional differentiation, and scenario analysis to stress-test strategic responses to trade-policy changes and supply-chain disruptions. Subject-matter experts reviewed draft findings to ensure technical accuracy and to confirm that conclusions were consistent with current clinical practice. Where applicable, methodological limitations and assumptions were explicitly documented to inform interpretation and to guide users in adapting insights to their specific operational contexts.

Concluding synthesis integrating clinical technological regulatory and commercial themes to clarify opportunities and strategic imperatives for stakeholders

The concluding synthesis integrates clinical, technological, regulatory, and commercial threads into a coherent set of strategic implications for stakeholders. Clinically driven decentralization, combined with advances in portable concentrator technology and supportive digital ecosystems, creates distinct pathways for growth in home healthcare and ambulatory settings while preserving the role of centralized liquid oxygen in specific high-volume contexts. Regulatory and policy shifts, including trade-related measures, are reshaping manufacturing and sourcing priorities, elevating the importance of regional production capability and supplier diversification.

Commercial success will hinge on the ability to align product innovation with demonstrable clinical value and reliable service delivery. Firms that can combine efficient device platforms with robust aftersales networks and data-enabled service offerings will be better positioned to capture durable customer relationships. In sum, the oxygen therapy device sector is entering a phase where clinical needs, technology maturation, and policy dynamics are collectively driving strategic differentiation; organizations that respond proactively with integrated product and service strategies will realize the greatest advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of IoT-enabled remote monitoring features in oxygen therapy devices to support telehealth services
  • 5.2. Development of hybrid oxygen concentrators combining continuous flow and pulse dose delivery for patient flexibility
  • 5.3. Expansion of home oxygen therapy reimbursement policies driving increased adoption among chronic respiratory patients
  • 5.4. Advancements in compact and lightweight portable oxygen devices enabling extended battery life for outdoor activities
  • 5.5. Emergence of AI-powered oxygen delivery systems optimizing flow rates based on real-time patient health metrics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Oxygen Therapy Devices Market, by Product Type

  • 8.1. Liquid Oxygen System
  • 8.2. Oxygen Concentrator
    • 8.2.1. Portable Oxygen Concentrator
    • 8.2.2. Stationary Oxygen Concentrator
  • 8.3. Oxygen Cylinder

9. Oxygen Therapy Devices Market, by Technology

  • 9.1. Cryogenic Distillation
  • 9.2. Membrane Separation
  • 9.3. Pressure Swing Adsorption

10. Oxygen Therapy Devices Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Home Healthcare
  • 10.3. Hospitals And Clinics

11. Oxygen Therapy Devices Market, by Application

  • 11.1. Asthma & Other Lung Diseases
  • 11.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 11.3. Obstructive Sleep Apnea (OSA)
  • 11.4. Pneumonia & Respiratory Distress Syndrome

12. Oxygen Therapy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Oxygen Therapy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Oxygen Therapy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Koninklijke Philips N.V.
    • 15.3.2. ResMed Inc.
    • 15.3.3. Chart Industries, Inc.
    • 15.3.4. Inogen, Inc.
    • 15.3.5. Drive DeVilbiss Healthcare, Inc.
    • 15.3.6. Invacare Corporation
    • 15.3.7. GE HealthCare Technologies Inc.
    • 15.3.8. Parker-Hannifin Corporation
    • 15.3.9. Nidek Medical Products, Inc.
    • 15.3.10. O2 Concepts, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. OXYGEN THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. OXYGEN THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OXYGEN THERAPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY LIQUID OXYGEN SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PORTABLE OXYGEN CONCENTRATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY STATIONARY OXYGEN CONCENTRATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CYLINDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CRYOGENIC DISTILLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY MEMBRANE SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRESSURE SWING ADSORPTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY ASTHMA & OTHER LUNG DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA (OSA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY PNEUMONIA & RESPIRATORY DISTRESS SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 136. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 172. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. MIDDLE EAST OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 184. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 185. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 186. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 187. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 210. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 222. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 223. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GCC OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. BRICS OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 258. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 259. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. G7 OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 270. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 271. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NATO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL OXYGEN THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 283. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED STATES OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 292. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 293. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 298. CANADA OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 299. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 302. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 303. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 304. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 305. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 307. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. MEXICO OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2018-2024 (USD MILLION)
  • TABLE 312. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATOR, 2025-2032 (USD MILLION)
  • TABLE 313. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. BRAZIL OXYGEN THERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM OXYGEN THERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)

TABLE